Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbie Zewdu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|February 8, 2020
Adipose Tumor MicroenvironmentAbbie Zewdu, Lucia Casadei, Raphael E Pollock, et al.
Journal of Surgical Oncology|April 8, 2021
Nerve transfers to restore femoral nerve function following oncologic nerve resectionAndrew L O'Brien, Julie M West, Abbie Zewdu, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|February 8, 2020
Adipose Tumor MicroenvironmentAbbie Zewdu, Lucia Casadei, Raphael E Pollock, et al.
Journal of Surgical Oncology|April 8, 2021
Nerve transfers to restore femoral nerve function following oncologic nerve resectionAndrew L O'Brien, Julie M West, Abbie Zewdu, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Pageof 1